Is your organization working on establishing a scalable DCT strategy for 2021 and beyond?
As an industry leader and pioneer in decentralized trials, Medable has developed a robust readiness framework that we use when assessing protocol-fit readiness for optimized DCT design with our clients. Join Rasmus Hogreffe and Andrew Mackinnon, as they uncover what it takes for organizations to be “ready” for the future of DCT.